FINWIRES · TerminalLIVE
FINWIRES

C.Q. Pharmaceutical Unit Gets China Regulatory Nod for Cardiovascular Drug

By

-- C.Q. Pharmaceutical (SHE:000950) subsidiary Chongqing Yaoyou Pharmaceutical obtained China's regulatory approval for sodium nitroprusside injection.

The drug is indicated for hypertensive emergencies and acute heart failure, according to a Thursday filing with the Shenzhen bourse.

Related Articles